Connect with us

Hi, what are you looking for?

Sunday, Apr 20, 2025
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Photo via Cannara Biotech Inc.

Business

Cannara Biotech ups annual sales 565% to $17.3M

While it’s now expanded to new markets, almost all of the firm’s 2020 sales were in Quebec

Licensed producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB) more than quadrupled its gross revenue, driven almost entirely by cannabis sales in Quebec.

The company released its earnings results for its fourth quarter and fiscal year ended Aug. 31, where it reported annual gross revenue of $17.3 million, rising 565 per cent from $2.6 million in its last fiscal year.

Cannara attributes the growth to its retail activities in Quebec, investments in operational development as well as licensing for two giant cultivation facilities spanning around 1.7 million square feet. The facilities have the potential to output around 125,000 kilograms of cannabis per year. The company said it sold around 1,700 kilograms of cannabis during its fourth quarter.

Operating expenses dropped 21 per cent to $10.3 million from $13.2 million last year. Gross profit increased 708 per cent to $10.5 million from $1.3 million.

Net losses fell 89 per cent to $1.5 million from $13.1 million. Total cash by the end of the year was up 5 per cent to $8.2 million.

Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) increased 118 per cent to $1.5 million from negative $8.3 million.

“Our impressive increase in revenue this quarter and incredible overall results for this year demonstrate a year of sustained growth and profitability, one which continued to drive our net income and adjusted EBITDA up,” CEO Zohar Krivorot said in a statement.

“Our three flagship brands carved unique niches in the industry, offering handcrafted, hang-dried, slow-cured and hand-trimmed cannabis with the flower’s natural properties intact.”

Read more: Canadian cannabis sales flat in September at $355M

Read more: Ontario’s cannabis distributor lacks transparency: auditor general report

In its fourth quarter, the company reported a 13-per-cent drop in net income to $1.1 million, from $1.7 million in the third quarter. Gross revenue also fell 13 per cent to $6.3 million, from $7.2 million.

Operating expenses totalled $3.0 million, from $2.2 million.

During the fourth quarter, the company expanded to Ontario and launched two new hash products under the Nugz brand in Quebec, as well as Old School Hash and Ice Water Hash.

Company stock rose by almost 4 per cent Wednesday to $0.14 on the TSX Venture Exchange.

This facility in Valleyfield, Quebec, is one of the world’s largest certified cannabis cultivation facilities. Photo via The Green Organic Dutchman

“The incredible performance, strong balance sheet and increase in gross profit all underscore our long-term growth strategy and commitment to our customers, against the backdrop of strong demand for our products, CFO Nicholas Sosiak said.

“As we continue to generate profitable growth and outsized returns, we will move forward from a position of financial strength and are ideally positioned to showcase continued positive adjusted EBITDA.”

In June, Cannara acquired a one-million-square-foot cultivation and manufacturing facility in Valleyfield, Quebec, from The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) (US-OTC: TGODF) in a $27-million transaction, plus funding of certain deposit requirements of around $5.7 million by a letter of credit.

The facility received its cultivation licence in September, and propagated its first 9,600 plants in November. 

Cannara recently introduced new products in Quebec including Cuban Linx and Do-Si-Dos via its Tribal brand and CBD Runtz via its Orchid CBD brand in both 3.5-gram dry flower and 2.5-gram pre-roll formats. Cannara also expanded to Saskatchewan in the fourth quarter.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

natalia@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Medical and Pharmaceutical

It will get phased in within the next 2 years

Psychedelics

"The Special Access Program is inefficient and insufficient," PsyCan's executive director said

Gold

Vancouver-based Equinox agreed to acquire Calibre in an all-stock deal to increase gold production and consolidate assets across the Americas

Gold

Collective is a gold, silver, copper, and tungsten exploration company with projects in Caldas, Colombia